Business · 18/12/2023
FDA Announces Draft Guidance for Priority Zoonotic Animal Drug Designation and Review Process
The FDA has released a draft guidance document to help pharmaceutical companies navigate the process of getting priority designation for new animal drugs that can treat zoonotic diseases, which are diseases that can be transmitted from animals to humans.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →